非ST段抬高型心肌梗死预后指标的研究进展  

Progress on Prognostic Indicators of Non-ST Elevated Myocardial Infarction

作　　者：张莉然 张子亚 韩翔宇[2] ZHANG Liran;ZHANG Ziya;HAN Xiangyu(Clinical Medicine School of Jining Medical College,Jining 272067,China;不详)

机构地区：[1]济宁医学院临床医学院,山东济宁272067 [2]济宁市第一人民医院

出　　处：《中外医学研究》2025年第9期177-180,共4页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：由于非ST段抬高型心肌梗死(NSTEMI)多合并多种慢性疾病,心血管不良事件(MACEs)发生率较高,为了更好地评估NSTEMI患者预后情况,文章针对全球急性冠状动脉事件注册(GRACE)评分等传统预测指标及新型生物学指标进行概述,以期为患者提供个性化诊疗方案。Since non-ST elevation myocardial infarction(NSTEMI)is associated with multiple chronic diseases and has a high incidence of major adverse cardiac events,MACEs(MACEs),in order to better evaluate the prognosis of NSTEMI patients,this paper summarized traditional predictors such as GRACE(Global Register of Acute Coronary Events)scores and novel biological indicators.In order to provide patients with personalized diagnosis and treatment plan.

关 键 词：非ST段抬高型心肌梗死 不良心血管事件 生物学指标 

分 类 号：R54[医药卫生—心血管疾病] R541.4[医药卫生—内科学]